Growth Metrics

Insulet (PODD) Work In Process (2010 - 2012)

Insulet posted quarterly Work In Process of $1.6 million for Q4 2012, up 344.29% year-on-year from $359000.0 in Q1 2012, and up 4.45% on a QoQ basis from $1.5 million in Q3 2012.

Insulet (PODD) has 3 years of Work In Process data on file, last reported at $1.6 million in Q4 2012.

  • For the quarter ending Q4 2012, Work In Process rose 344.29% year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2012 stood at $1.6 million (up 344.29% YoY), and the FY2012 full-year result was $1.6 million, up 344.29% from the prior year.
  • Work In Process for Q4 2012 stood at $1.6 million, up from $1.5 million in the prior quarter.
  • Across five years, Work In Process topped out at $2.4 million in Q4 2010 and bottomed at $359000.0 in Q4 2011.
  • The 3-year median for Work In Process is $1.6 million (2012), against an average of $1.4 million.
  • The widest annual swing landed in 2011, when Work In Process sank 84.9%; it then jumped 344.29% in 2012.
  • A 3-year view of Work In Process shows it stood at $2.4 million in 2010, then tumbled by 84.9% to $359000.0 in 2011, then surged by 344.29% to $1.6 million in 2012.
  • The last three Work In Process figures came in at $1.6 million (Q4 2012), $1.5 million (Q3 2012), and $2.0 million (Q2 2012), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2012 1.60 Mn
Sep 30, 2012 1.53 Mn
Jun 30, 2012 2.03 Mn
Mar 31, 2012 560,000.00
Dec 31, 2011 359,000.00
Dec 31, 2010 2.38 Mn